World's First Commercial Implants of the Evoke System Completed in The Netherlands­­­­ARTARMON, Australia, Sept. 16, 2019 /PRNewswire/ -- Saluda M ...

Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of chronic pain.

Findings demonstrated that the EVOKE SCS System was superior to open-loop stimulation for pain relief at 3 months (P =.005) and 12 months (P =.006).

St. Jude Medical Inc.STJ recently announced the receipt of FDA approval for its new upgradeable and recharge-free Spinal Cord Stimulation (SCS) System - Proclaim Elite. The company also received ...

Nevro is the top pure play SCS company. Its recent FDA approvals for its high frequency SCS system in treatment of PDN and NSRBP are game changers. Read to know why it's a Hold.

The Senza SCS System is a neuromodulation device designed to deliver electrical stimulation using implantable leads and a rechargeable, implantable pulse generator. The Food and Drug ...

The Prospera SCS system for pain management relieved pain, improved sleep and reduced opioid use at 24 months, according to interim results of the BENEFIT-03 study.Healio spoke with BIOTRONIK ...

The Proclaim Elite SCS System offers patients a combination of the convenience of a device that doesn’t require recharging while offering access to St. Jude Medical BurstDR stimulation technology.